Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
In a report published in Science Robotics, researchers claim to have created microrobots that can successfully traverse the blood-brain barrier in mice. The team from Harbin Institute of…
What are the latest treatment options for patients with #AML? @manosnikolousis discusses treatment options with a clinical nurse specialist and a patient with AML.
At their Ignite digital conference on March 2, 2021, Microsoft unveiled a technology meant to enable device- and location-agnostic “shared experiences” via mixed reality applications. Learn more about…
